Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Why Teva Stock Trounced the Market on Friday
05:04pm, Friday, 05'th Aug 2022
Bank of America finds its inner bull with the generics producer.
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
03:27pm, Friday, 05'th Aug 2022 Benzinga
Following Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) opioid settlement, the Tel Aviv-Yafo, Israel-based company seems to be making “material progress” in clearing its litigation overhang
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
02:43pm, Friday, 05'th Aug 2022 Benzinga
Upgrades
For 8x8 Inc (NYSE:EGHT), Craig-Hallum upgraded the previous rating of Hold to Buy. In the first quarter, 8x8 showed an EPS of $0.09, compared to $0.01 from the year-ago quarter. At the moment
Synaptics To $205? Plus Stifel Cuts Twilio's PT From $200 To This Level
01:30pm, Friday, 05'th Aug 2022 Benzinga
Stifel cut the price target for Twilio Inc. (NYSE: TWLO) from $200 to $90. Twilio shares fell 9.6% to $88.75 in pre-market trading.
B of A Securities boosted the price target on Teva Pharmaceutical
Is This Rare Berkshire Hathaway Miscue Finally a Buy?
12:25pm, Wednesday, 03'rd Aug 2022 The Motley Fool
Berkshire Hathaway cut bait with the struggling drugmaker Teva Pharmaceutical Industries in late 2021.
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
12:47pm, Tuesday, 02'nd Aug 2022 Benzinga
Analysts have provided the following ratings for Teva Pharmaceutical Indus (NYSE:TEVA) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
0
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30%
01:10pm, Thursday, 28'th Jul 2022
Teva posted second-quarter results that exceeded market expectations. Teva's outlook looks bright.
PayPal, Alphabet And Some Other Big Stocks Recording Gains On Wednesday
09:24am, Thursday, 28'th Jul 2022 Benzinga
U.S. stocks closed sharply higher on Wednesday, with the Dow Jones jumping more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Pzena Investment Management
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
08:22am, Thursday, 28'th Jul 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Ch
Dow Rises 150 Points As Fed Boosts Rates By 0.75 Percentage Points
06:05pm, Wednesday, 27'th Jul 2022 Benzinga
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday.
The Dow traded up 0.49% to 31,915.65 while the NASDAQ rose 2.83% to 11,889.90. The S&
Teva Pharmaceutical Industries (TEVA) Q2 2022 Earnings Call Transcript
06:00pm, Wednesday, 27'th Jul 2022 The Motley Fool
TEVA earnings call for the period ending June 30, 2022.
Nasdaq Jumps Over 300 Points; Boeing Posts Wider-Than-Expected Loss
04:38pm, Wednesday, 27'th Jul 2022 Benzinga
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.
The Dow traded up 0.45% to 31,904.19 while the NASDAQ rose 2.77% to 11,883.01. Th
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
04:07pm, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Med
TEVA Beats on Q2 Earnings, to Settle Opioid Lawsuit for $4.3B
02:32pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
TEVA reports mixed Q2 results. It lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact. The company agrees to settle opioid lawsuits for as much as $4.2
Teva Pharmaceutical Industries Limited's (TEVA) CEO Kare Schultz on Q2 2022 Results - Earnings Call Transcript
12:17pm, Wednesday, 27'th Jul 2022
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q2 2022 Earnings Conference Call July 27, 2022 8:00 AM ET Company Participants Ran Meir – Senior Vice President, Head of Investor Relations Kare S
